PharmaEssentia
Company: PharmaEssentia Corporation
Bloomberg ticker: 6446 TT
Market cap: US$7,259m
Background: PharmaEssentia Corporation develops and distributes drugs to treat hepatitis, chronic myeloid leukemia, essential thrombocythemia, myeloid fibrosis, polycythemia vera, hepatitis, and cancer. The company was founded in 2003 by a group of Taiwanese-American executives and scientists from American biotech and pharmaceutical companies.
World Class Benchmarking of PharmaEssentia Corp
(Click on image to enlarge)
- Profitable Growth rank of 6 was up compared to the prior period’s 9th rank
- This is below average performance compared to 350 medium Health Care companies worldwide
- Profitability rank of 6 was worse than its Growth rank of 2
- Profitability rank of 6 was up compared to the prior period’s 9th rank
- This is below average performance compared to peers
- Growth rank of 2 was the same compared to the prior period’s 2nd rank
- This is World Class performance compared to peers
More By This Author:
Asian Stock: Jiangsu Hengrui PharmaceuticalsAsian Stock: Zhejiang China Commodities City Group
Asian Stock: President Chain Store Corp
Disclaimer: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and ...
more
How did you like this article? Let us know so we can better customize your reading experience.
Comments
Leave a comment to automatically be entered into
our contest to win a free Echo Show.
